Drug Shortage Report for IRINOTECAN HYDROCHLORIDE INJECTION USP

Last updated on 2025-10-08 History
Report ID 258027
Drug Identification Number 02258218
Brand name IRINOTECAN HYDROCHLORIDE INJECTION USP
Common or Proper name IRINOTECAN HYDROCHLORIDE INJECTION USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) IRINOTECAN HYDROCHLORIDE
Strength(s) 20MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 25ML VIAL
ATC code L01CE
ATC description
Reason for shortage Demand increase for the drug.
Anticipated start date 2025-08-15
Actual start date
Estimated end date
Actual end date 2025-10-07
Shortage status Resolved
Updated date 2025-10-08
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2025-10-08 English Compare
v12 2025-10-07 French Compare
v11 2025-10-07 English Compare
v10 2025-09-30 French Compare
v9 2025-09-30 English Compare
v8 2025-08-16 English Compare
v7 2025-08-06 French Compare
v6 2025-08-06 English Compare
v5 2025-07-30 French Compare
v4 2025-07-30 English Compare
v3 2025-07-17 English Compare
v2 2025-05-21 French Compare
v1 2025-05-21 English Compare

Showing 1 to 13 of 13